| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $4.6B | $4.9B | $5.6B | $5.8B | $1.4B | $1.3B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | $-0.1B | $-0.2B | $-0.4B | $0.5B | $0.5B | $0.3B |
| Net Income | $0.1B | $0.3B | $-0.3B | $-0.3B | $-0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $2.31 | $4.95 | $-4.25 | $-4.72 | $-1.87 | $1.49 | $1.87 | $0.10 |
| EPS (Diluted) | $2.29 | $4.91 | $-4.25 | $-4.72 | $-1.87 | $1.46 | $1.85 | $0.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $12.6B | $12.7B | $13.4B | $14.9B | $14.3B | $13.0B | $11.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B |
| Total Liabilities | $9.8B | $9.8B | $10.2B | $10.9B | $10.9B | $9.8B | $9.0B | $8.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.7B | $2.8B | $2.5B | $2.4B | $4.0B | $4.6B | $4.0B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.4B | $-0.1B | $-0.2B | $0.4B | $0.4B | $0.5B | $0.5B |
| Investing Cash Flow | $0.3B | $-0.2B | $0.1B | $-0.1B | $-0.1B | $-0.8B | $-0.6B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.9B | $-0.1B | $-0.1B | $0.4B | $-0.3B | $0.4B | $0.2B | $-0.0B |